Vitamin D Status and Lipid Profile in Obese Adults With Type 2 Diabetes
VILD-T2D
Association Between Serum 25-Hydroxyvitamin D Status and Lipid Profile Among Obese Adults With Type 2 Diabetes Mellitus: A Cross-Sectional Study
1 other identifier
observational
150
0 countries
N/A
Brief Summary
This prospective, single-center, cross-sectional observational study aims to evaluate the association between serum 25-hydroxyvitamin D concentrations and lipid profile parameters among adults with obesity and established type 2 diabetes mellitus. A total of 160 participants will be recruited from an outpatient diabetes clinic in Cairo, Egypt. Each participant will undergo a single clinical, anthropometric, and laboratory assessment. No intervention or treatment will be assigned by the investigators.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2026
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 22, 2026
CompletedStudy Start
First participant enrolled
July 25, 2026
CompletedFirst Posted
Study publicly available on registry
July 27, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 28, 2027
July 27, 2026
July 1, 2026
5 months
July 22, 2026
July 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Lipid Profile According to Serum 25-Hydroxyvitamin D Status
Measurement of serum lipid parameters including: Total cholesterol (mg/dL) Triglycerides (mg/dL) High-density lipoprotein cholesterol (HDL-C, mg/dL) Low-density lipoprotein cholesterol (LDL-C, mg/dL)
At the baseline study visit (single assessment)
Secondary Outcomes (4)
Fasting Blood Glucose
At the baseline study visit (single assessment)
Postprandial Blood Glucose
At the baseline study visit (single assessment)
Glycated Hemoglobin (HbA1c)
At the baseline study visit (single assessment)
Serum Insulin
At the baseline study visit (single assessment)
Study Arms (2)
Lower Vitamin D Status Group
Participants with obesity and established type 2 diabetes mellitus who have lower serum 25-hydroxyvitamin D \[25(OH)D\] concentrations according to the predefined study criteria. Vitamin D deficiency is defined as serum 25(OH)D concentration below 20 ng/mL. Participants in this group will undergo clinical and laboratory assessments, including lipid profile and glycemic measurements, to evaluate metabolic characteristics associated with lower vitamin D status.
Higher Vitamin D Status Group
Participants with obesity and established type 2 diabetes mellitus who have higher serum 25-hydroxyvitamin D \[25(OH)D\] concentrations according to the predefined study criteria. Participants in this group will undergo the same clinical and laboratory assessments, including lipid profile and glycemic measurements, for comparison with the lower vitamin D status group.
Eligibility Criteria
Adults with obesity and established type 2 diabetes mellitus attending an outpatient diabetes clinic.
You may qualify if:
- Adults aged 18 years or older.
- Established diagnosis of type 2 diabetes mellitus (T2DM) according to standard diagnostic criteria.
- Obesity based on body mass index (BMI) criteria.
- Availability of serum 25-hydroxyvitamin D \[25(OH)D\] measurement.
- Availability of lipid profile and glycemic laboratory parameters.
- Ability and willingness to provide written informed consent.
You may not qualify if:
- Type 1 diabetes mellitus.
- Pregnancy.
- Known chronic kidney disease.
- Chronic liver disease.
- Active malignancy.
- Acute infection or inflammatory disease.
- Conditions affecting gastrointestinal absorption.
- Use of medications or supplements that substantially alter vitamin D metabolism (when applicable).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sinai Universitylead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer
Study Record Dates
First Submitted
July 22, 2026
First Posted
July 27, 2026
Study Start
July 25, 2026
Primary Completion (Estimated)
December 30, 2026
Study Completion (Estimated)
February 28, 2027
Last Updated
July 27, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared publicly. The study data contain potentially identifiable health information, and participant consent and institutional ethical approval did not include unrestricted public release of individual-level data. Requests for data access may be considered by the corresponding author upon reasonable request and subject to institutional and ethical approval.